31 Aug 2026, 11:36 AM 2 min readentertainmentanalysis
Hanuman Ansh Box Office Surge Challenges Toxic
Box Office Divergence:
The devotional drama Hanuman Ansh continues a strong run at the box office, having reached ₹27 crore in earnings over a 23-day period. The film recently showcased significant momentum, recording a 228 percent growth on its fourth Friday, which helped it cross the ₹20 crore milestone during its theatrical run.
Market Performance Contrast:
In contrast to the steady growth of the devotional project, the Yash-starrer Toxic has experienced a notable decline in commercial performance. Despite crossing the ₹200 crore mark in India within its first four days, the film has faced a downward trend, moving into a slump that contrasts sharply with the recent surge seen by smaller-budget competitors.
Industry Implications:
This shift highlights changing audience preferences as high-budget star-driven spectacles face fatigue while genre-specific films find a sustained audience. Analysts are observing whether the momentum for Hanuman Ansh can hold as it faces new releases, while Toxic attempts to stabilize its numbers after an initially rapid ascent. The commercial divergence signals a competitive period for the Indian box office landscape.
Pulse Intelligence
Context & ImpactContext & Background
- The Indian film industry has recently seen a trend of high-budget releases facing rapid box office drops after strong openings.
- Devotional and genre-specific films have occasionally defied expectations by showing strong weekend growth weeks after release.
Key Consequences
- The sustained performance of Hanuman Ansh may encourage producers to invest more in regional and devotional narratives.
- Toxic will likely require strong international performance to maintain its commercial standing after the domestic decline.
Market & Economic Impact
No direct market impact.
The Indus Pulse is committed to accuracy and transparency.

